Participants with the highest body mass index (BMI) values (40 or above) were most likely to access semaglutide, which is not surprising given that this group has the highest risk for developing further metabolic diseasebut Podolsky says it reflects a trend that physicians may be restricting GLP-1 drugs to patients with the highest weight, and solely recommending lifestyle interventions to patients with BMI values of 35 or less
The vials are labeled "for research purposes only, not for human consumption." This labeling is what allows them to sell the product without FDA approval, since technically they are selling a lab chemical, not a medicine
Burgetova A, Dusek P, Uher T, Vaneckova M, Vejrazka M, Burgetova R, et al
Glutathione and glutathione derivatives in immunotherapy
Furthermore, the importance of the ARC, but not the PVN, for liraglutide-induced weight loss, as delineated by Secher et al., is in direct contrast to findings from Sandoval et al